Bank of Montreal
NERV icon

Bank of Montreal’s Minerva Neurosciences NERV Stock Holding History

Bank of Montreal’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,000
Closed -$97 – 4191
2022
Q3 		$97 Buy
+10,000
New +$59.2K ﹤0.01% 3476
2021
Q2 		– Sell
-133
Closed -$3K – 4497
2021
Q1 		$3K Sell
133
-560
-81% -$14K ﹤0.01% 4830
2020
Q4 		$14K Buy
693
+495
+250% +$12.5K ﹤0.01% 4566
2020
Q3 		$6K Sell
198
-121
-38% -$3.27K ﹤0.01% 4353
2020
Q2 		$9K Buy
+319
New +$18.7K ﹤0.01% 4220
2020
Q1 		– Sell
-471
Closed -$27K – 4493
2019
Q4 		$27K Buy
471
+147
+45% +$6.48K ﹤0.01% 4143
2019
Q3 		$20K Sell
324
-1,239
-79% -$70.2K ﹤0.01% 4090
2019
Q2 		$70K Sell
1,563
-355
-19% -$17.8K ﹤0.01% 3529
2019
Q1 		$120K Sell
1,918
-54
-3% -$3.25K ﹤0.01% 2981
2018
Q4 		$107K Buy
1,972
+28
+1% +$2.05K ﹤0.01% 2920
2018
Q3 		$195K Sell
1,944
-1
-0.1% -$75 ﹤0.01% 2771
2018
Q2 		$128K Buy
1,945
+679
+54% +$41.2K ﹤0.01% 3003
2018
Q1 		$63K Buy
+1,266
New +$60.8K ﹤0.01% 3142
2016
Q3 		– Sell
-1,913
Closed -$156K – 4138
2016
Q2 		$156K Buy
+1,913
New +$122K ﹤0.01% 2594

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of Montreal's NERV Position: Q4 2022 in Review

Bank of Montreal sold out of Minerva Neurosciences (NERV) in Q4 2022, closing a stake of 10,000 shares — an estimated $97 sold.

Bank of Montreal first reported a position in NERV in Q2 2016 and held it in 14 quarters. The position peaked at $195K in Q3 2018. 19 funds tracked by Wall St. Rank hold NERV as of Q4 2022.

  • Bank of Montreal reported no remaining Minerva Neurosciences position as of Q4 2022 after selling out during the quarter.
  • Bank of Montreal sold 10,000 Minerva Neurosciences shares in Q4 2022, an estimated $97.
  • Bank of Montreal first reported a position in Minerva Neurosciences in Q2 2016 and held it in 14 quarters.
  • Bank of Montreal's Minerva Neurosciences position peaked at $195K in Q3 2018.
  • 19 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2022.

Based on Bank of Montreal's 13F filing for Q4 2022, filed 1 Feb 2023.